Midatech Pharma (LON:MTPH) Announces Earnings Results

Midatech Pharma (LON:MTPH) issued its quarterly earnings results on Thursday. The company reported GBX (64) (($0.84)) EPS for the quarter, Digital Look Earnings reports.

MTPH traded up GBX 0.80 ($0.01) during trading on Thursday, reaching GBX 33.30 ($0.44). 383,589 shares of the stock traded hands, compared to its average volume of 642,232. The stock’s 50-day moving average is GBX 37.01 and its 200 day moving average is GBX 28.05. The company has a quick ratio of 2.40, a current ratio of 2.42 and a debt-to-equity ratio of 35.74. Midatech Pharma has a 12 month low of GBX 15 ($0.20) and a 12 month high of GBX 160 ($2.09). The stock has a market capitalization of $20.49 million and a PE ratio of -0.61.

Midatech Pharma Company Profile

Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. The company operates through two segments, Pipeline Research and Development; and Commercial. Its products include Zuplenz, an oral soluble film for moderately emetogenic chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting; Gelclair, an oral gel barrier device indicated for the management and relief of pain due to oral mucositis; Oravig, an orally dissolving buccal tablet for oral thrush; and Soltamox, an oral liquid solution of tamoxifen citrate, for the treatment and prevention of breast cancer.

Featured Story: Oversold

Receive News & Ratings for Midatech Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Midatech Pharma and related companies with MarketBeat.com's FREE daily email newsletter.